Analysed EMERGENT BIOSOLUTIONS INC (EBS:NYSE) News Sources
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
30-04-2026
yahoo.com
Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ...
01-05-2026
yahoo.com
Emergent BioSolutions Shares Turnaround Update at 2026 Annual Meeting; All Proposals Approved
02-05-2026
marketbeat.com
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
18-05-2026
yahoo.com
Emergent BioSolutions Inc. (EBS) Gains Attention as ACAM2000 Receives Broader Public Health Authorization
20-05-2026
yahoo.com
What is the current price of EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The current price of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is $8.57.
EMERGENT BIOSOLUTIONS INC (EBS:NYSE) absolute price change since previous trading day?
The absolute price change of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) since the previous trading day is $-0.55.
EMERGENT BIOSOLUTIONS INC (EBS:NYSE) percentage price change since previous trading day?
The percentage price change of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) since the previous trading day is -6.0307%.
What is the most recent average sentiment score for EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The most recent average sentiment score for EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is 70 out of 100.
What is the most recent average sentiment for EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The most recent sentiment for EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is .
SEC-8K** Filing Available For EMERGENT BIOSOLUTIONS INC (EBS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.